Miller D T, Shen Y, Weiss L A, Korn J, Anselm I, Bridgemohan C, Cox G F, Dickinson H, Gentile J, Harris D J, Hegde V, Hundley R, Khwaja O, Kothare S, Luedke C, Nasir R, Poduri A, Prasad K, Raffalli P, Reinhard A, Smith S E, Sobeih M M, Soul J S, Stoler J, Takeoka M, Tan W-H, Thakuria J, Wolff R, Yusupov R, Gusella J F, Daly M J, Wu B-L
Department of Laboratory Medicine, Children's Hospital Boston, 300 Longwood Ave, Boston, Massachusetts 02115, USA.
J Med Genet. 2009 Apr;46(4):242-8. doi: 10.1136/jmg.2008.059907. Epub 2008 Sep 19.
Segmental duplications at breakpoints (BP4-BP5) of chromosome 15q13.2q13.3 mediate a recurrent genomic imbalance syndrome associated with mental retardation, epilepsy, and/or electroencephalogram (EEG) abnormalities.
DNA samples from 1445 unrelated patients submitted consecutively for clinical array comparative genomic hybridisation (CGH) testing at Children's Hospital Boston and DNA samples from 1441 individuals with autism from 751 families in the Autism Genetic Resource Exchange (AGRE) repository.
We report the clinical features of five patients with a BP4-BP5 deletion, three with a BP4-BP5 duplication, and two with an overlapping but smaller duplication identified by whole genome high resolution oligonucleotide array CGH. These BP4-BP5 deletion cases exhibit minor dysmorphic features, significant expressive language deficits, and a spectrum of neuropsychiatric impairments that include autism spectrum disorder, attention deficit hyperactivity disorder, anxiety disorder, and mood disorder. Cognitive impairment varied from moderate mental retardation to normal IQ with learning disability. BP4-BP5 covers approximately 1.5 Mb (chr15:28.719-30.298 Mb) and includes six reference genes and 1 miRNA gene, while the smaller duplications cover approximately 500 kb (chr15:28.902-29.404 Mb) and contain three reference genes and one miRNA gene. The BP4-BP5 deletion and duplication events span CHRNA7, a candidate gene for seizures. However, none of these individuals reported here have epilepsy, although two have an abnormal EEG.
The phenotype of chromosome 15q13.2q13.3 BP4-BP5 microdeletion/duplication syndrome may include features of autism spectrum disorder, a variety of neuropsychiatric disorders, and cognitive impairment. Recognition of this broader phenotype has implications for clinical diagnostic testing and efforts to understand the underlying aetiology of this syndrome.
15号染色体q13.2q13.3断点(BP4 - BP5)处的节段性重复介导了一种与智力迟钝、癫痫和/或脑电图(EEG)异常相关的复发性基因组失衡综合征。
连续提交至波士顿儿童医院进行临床阵列比较基因组杂交(CGH)检测的1445名无血缘关系患者的DNA样本,以及来自自闭症遗传资源交换库(AGRE)中751个家庭的1441名自闭症患者的DNA样本。
我们报告了5例BP4 - BP5缺失患者、3例BP4 - BP5重复患者以及2例通过全基因组高分辨率寡核苷酸阵列CGH鉴定出的重叠但较小重复患者的临床特征。这些BP4 - BP5缺失病例表现出轻微的畸形特征、显著的表达性语言缺陷以及一系列神经精神障碍,包括自闭症谱系障碍、注意力缺陷多动障碍、焦虑症和情绪障碍。认知障碍程度从中度智力迟钝到具有学习障碍的正常智商不等。BP4 - BP5覆盖约1.5 Mb(chr15:28.719 - 30.298 Mb),包含6个参考基因和1个miRNA基因,而较小的重复覆盖约500 kb(chr15:28.902 - 29.404 Mb),包含3个参考基因和1个miRNA基因。BP4 - BP5缺失和重复事件跨越CHRNA7,这是一个癫痫候选基因。然而,尽管有2例患者脑电图异常,但这里报告的这些个体均无癫痫发作。
15号染色体q13.2q13.3 BP4 - BP5微缺失/重复综合征的表型可能包括自闭症谱系障碍、多种神经精神障碍和认知障碍的特征。认识到这一更广泛的表型对临床诊断测试以及理解该综合征潜在病因的努力具有重要意义。